Ebos profit falls but dividend holds steady as Chemist Warehouse era ends

Ebos profit falls but dividend holds steady as Chemist Warehouse era ends
Ebos has invested about $360m in new facilities including room to store the increasingly popular weight loss drugs such as Wegovy. (Image: Getty)
Rebecca Stevenson
Ebos’ profit has fallen, but it will pay investors the same dividend as it moves on without the Chemist Warehouse contract. For the year to June 30, the health and animal care group reported revenue of A$12.3 billion (NZ$13.6b) and underlying earnings of A$585 million. Its guidance was for underlying earnings before interest, taxation, depreciation and amortisation (ebitda) of between A$575m and A$600m. Revenue dropped 7.0% compared to the previous financial year.  It lost the $1.9b Chemist Warehouse contract in 2023....

More Markets

Precinct looking for capital partners for PwC Tower
Property

Precinct looking for capital partners for PwC Tower

Precinct Properties wants to finance its last Commercial Bay development.

Meridian Energy slumps to $452 million net loss
Markets

Meridian Energy slumps to $452 million net loss

Meridian Energy slumped to a $452 million net loss in the June year, driven by a steep decline in its energy margins arising from two severe droughts.The company said its cash flow fell to $318m in the year, down from $667m in the previous year.The generator-retailer’s net loss c...

Analysts say Scales is bearing fruit
Markets

Analysts say Scales is bearing fruit

Scales reported a solid 1H result, according to analysts.

Analysts eye upside in Vulcan acquisition
Markets

Analysts eye upside in Vulcan acquisition

“It's part of their DNA to add on acquisitions they believe are accretive.”